As of the latest SEC filings, COMPASS Pathways plc (CMPS) is held by 17 institutional funds. The largest fund shareholder is ARK Genomic Revolution ETF (ARKG), holding an estimated $30,043,648.56 in market value, representing 2.43% of its portfolio.
Funds holding COMPASS Pathways plc (CMPS)
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- CMPS
- CIK:
- 0001816590
| Fund | Type | Manager | Weight | Market Value | Shares |
Report Date
|
Filing Date
|
|---|---|---|---|---|---|---|---|
|
ARKG
ARK Genomic Revolution ETF
|
ETF | Independent / Boutique | 2.43% | $30,043,648.56 | 3,316,076 | Apr 30, 2026 | Jun 23, 2026 |
|
PHLQX
PGIM Jennison Health Sciences Fund
|
MF | PGIM / Prudential | 0.29% | $4,212,519.00 | 610,510 | Feb 27, 2026 | Apr 23, 2026 |
|
CSMIX
Columbia Small Cap Value Discovery Fund
|
MF | Columbia Threadneedle | 0.17% | $3,813,444.60 | 420,910 | Apr 30, 2026 | Jun 25, 2026 |
|
IBB
iShares Biotechnology ETF
|
ETF | BlackRock / iShares | 0.04% | $3,385,189.50 | 612,150 | Mar 31, 2026 | May 28, 2026 |
|
RYVPX
Royce Smaller-Companies Growth Fund
|
MF | Independent / Boutique | 0.77% | $1,376,970.00 | 249,000 | Mar 31, 2026 | May 21, 2026 |
|
PSIL
AdvisorShares Psychedelics ETF
|
ETF | Independent / Boutique | 6.74% | $1,364,466.67 | 246,739 | Mar 31, 2026 | May 21, 2026 |
|
SURI
Simplify Propel Opportunities ETF
|
ETF | Independent / Boutique | 1.27% | $879,557.56 | 159,052 | Mar 31, 2026 | May 27, 2026 |
|
RVT
ROYCE SMALL-CAP TRUST, INC.
|
CEF | Independent / Boutique | 0.03% | $735,490.00 | 133,000 | Mar 31, 2026 | May 21, 2026 |
|
BRW
Saba Capital Income & Opportunities Fund
|
CEF | Independent / Boutique | 0.14% | $554,363.28 | 61,188 | Apr 30, 2026 | Jun 26, 2026 |
|
-
Columbia Variable Portfolio - Small Cap Value Fund
|
ETF | Columbia Threadneedle | 0.12% | $464,243.50 | 83,950 | Mar 31, 2026 | May 28, 2026 |
|
GWX
State Street(R) SPDR(R) S&P(R) International Small Cap ETF
|
ETF | State Street (SPDR) | 0.05% | $444,844.26 | 80,442 | Mar 31, 2026 | May 28, 2026 |
|
FNCMX
Fidelity Nasdaq Composite Index Fund
|
MF | Fidelity | 0.00% | $434,437.80 | 62,962 | Feb 28, 2026 | Apr 24, 2026 |
|
BBC
Virtus Biotech Clinical Trials Etf
|
ETF | Independent / Boutique | 0.99% | $371,007.00 | 40,950 | Apr 30, 2026 | Jun 22, 2026 |
|
-
TIFF MULTI-ASSET FUND
|
ETF | Independent / Boutique | 0.02% | $320,341.84 | 57,928 | Mar 31, 2026 | Jun 1, 2026 |
|
BXMYX
Blackstone Alternative Multi-Strategy Fund
|
MF | Independent / Boutique | 0.00% | $69,125.00 | 12,500 | Mar 31, 2026 | May 27, 2026 |
|
IBBQ
Invesco Nasdaq Biotechnology ETF
|
ETF | Invesco | 0.05% | $36,287.10 | 5,259 | Feb 28, 2026 | Apr 28, 2026 |
|
BIB
ProShares Ultra Nasdaq Biotechnology
|
ETF | ProShares | 0.03% | $30,021.90 | 4,351 | Feb 28, 2026 | Apr 24, 2026 |
Advertisement (320x50)